TAMPA, Fla.--(BUSINESS WIRE)--Sept. 19, 2005--Stem Cell Therapy International, Inc. (OTC: ATYD - News) today announced that it has signed an exclusive global Licensing Agreement with the Institute of Cell Therapy (ICT) a biotechnology company incorporated and organized in Kiev, Ukraine, for the supply of stem cells and use of 26 related patents.
